Clinical trial
Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia
NCT00243399 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00243399 |
|---|---|
| Title | Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia |
| Official title | A Pilot Trial of Oxandrolone for the Treatment of Bone Marrow Aplasia in Patients With Fanconi Anemia |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | FDA Office of Orphan Products Development U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fanconi Anemia |
| Intervention type | Drug |
| Interventions | Oxandrolone |
| Enrollment | 10 |
| Start date | Jul 1, 2004 |
| Primary completion | Dec 1, 2009 |
| Completion | Jan 1, 2010 |
| First posted | Oct 24, 2005 |
| Last update posted | Jul 15, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: